The pharmacology of stuttering: a critical review
- PMID: 1680295
- DOI: 10.1176/ajp.148.10.1309
The pharmacology of stuttering: a critical review
Abstract
Objective: The author critically examines the limited world literature on pharmacologic treatments of stuttering.
Method: The literature on stuttering and drugs was identified by means of two computer-assisted searches.
Findings: A great variety of pharmacologic agents have been used to treat stuttering, reflecting the many theories about the origin and nature of the disorder. In some instances new hypotheses about the nature of stuttering have followed the chance discovery of agents having some efficacy.
Conclusions: Few studies have used adequate experimental designs. Promising avenues of research, both for the treatment of stuttering and for exploring its nature, include the use of calcium channel blocking agents and cholinergic drugs.
Comment in
-
Antidepressants and the treatment of stuttering.Am J Psychiatry. 1992 Sep;149(9):1281. doi: 10.1176/ajp.149.9.1281a. Am J Psychiatry. 1992. PMID: 1503152 No abstract available.
-
Clonidine and stuttering.Am J Psychiatry. 1992 May;149(5):717-8. doi: 10.1176/ajp.149.5.717. Am J Psychiatry. 1992. PMID: 1575277 Clinical Trial. No abstract available.
-
Treatment of stuttering with phenelzine.Am J Psychiatry. 1993 Feb;150(2):355-6. doi: 10.1176/ajp.150.2.355. Am J Psychiatry. 1993. PMID: 8422103 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
